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No agreement of mixed venous and central venous
saturation in sepsis, independent of sepsis origin
Paul A van Beest1*, Jan van Ingen2, E Christiaan Boerma3, Nicole D Holman2, Henk Groen4, Matty Koopmans3,
Peter E Spronk5,6, Michael A Kuiper3,6
Abstract
Introduction: Controversy remains regarding the relationship between central venous saturation (ScvO2) and
mixed venous saturation (SvO2) and their use and interchangeability in patients with sepsis or septic shock. We
tested the hypothesis that ScvO2 does not reliably predict SvO2 in sepsis. Additionally we looked at the influence
of the source (splanchnic or non-splanchnic) of sepsis on this relationship.
Methods: In this prospective observational two-center study we concurrently determined ScvO2 and SvO2 in a
group of 53 patients with severe sepsis during the first 24 hours after admission to the intensive care units in
2 Dutch hospitals. We assessed correlation and agreement of ScvO2 and SvO2, including the difference, i.e. the
gradient, between ScvO2 and SvO2 (ScvO2 - SvO2). Additionally, we compared the mean differences between
ScvO2 and SvO2 of both splanchnic and non-splanchnic group.
Results: A total of 265 paired blood samples were obtained. ScvO2 overestimated SvO2 by less than 5% with wide
limits of agreement. For changes in ScvO2 and SvO2 results were similar. The distribution of the (ScvO2 - SvO2)
(<0 or ≥ 0) was similar in survivors and nonsurvivors. The mean (ScvO2 - SvO2) in the splanchnic group was similar
to the mean (ScvO2 - SvO2) in the non-splanchnic group (0.8 ± 3.9% vs. 2.5 ± 6.2%; P = 0.30). O2ER (P = 0.23) and
its predictive value for outcome (P = 0.20) were similar in both groups.
Conclusions: ScvO2 does not reliably predict SvO2 in patients with severe sepsis. The trend of ScvO2 is not
superior to the absolute value in this context. A positive difference (ScvO2 - SvO2) is not associated with improved
outcome.
Introduction
Global tissue hypoxia as a result of systemic inflamma-
tory response or circulatory failure is an important indi-
cator of serious illness preceding multiple organ failure.
The development of organ failure predicts outcome of
the septic patient [1]. Unrecognized and untreated glo-
bal tissue hypoxia increases morbidity and mortality:
decreased mixed venous saturation (SvO2) values predict
poor prognosis in septic shock [2-4]. Controversy, how-
ever, remains: there is no clear evidence that guiding
hemodynamic optimization by monitoring central
venous saturation (ScvO2) or SvO2 is useful in all
patients with sepsis or septic shock, especially in the
intensive care unit (ICU). The controversy includes the
interchangeability of ScvO2 and SvO2 [5,6]. Also, in
patients with a splanchnic cause of sepsis, ScvO2 may be
normal, whereas the SvO2 may be decreased because of
elevated metabolic demand. On the other hand, owing
to sepsis-related vasodilatation (also in the digestive
tract) leading to diminished oxygen consumption, SvO2
may be normal [7]. This could mean that the 5% differ-
ence between ScvO2 and SvO2 is not as consistent in
sepsis as postulated earlier [8,9]. Nevertheless, recently,
an association between a positive O2 gradient (ScvO2 -
SvO2 ≥0) and ICU survival in critically ill patients was
described [10]. Therapy aimed at increasing this gradi-
ent could mean improved survival. However, this
demands measurement of both ScvO2 and SvO2.
We tested the hypothesis that ScvO2 does not reliably
predict SvO2 in sepsis; that is, a consistent 5% difference
between ScvO2 and SvO2 does not exist. We also looked
at the possible relationship between a positive difference
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between ScvO2 and SvO2 (ScvO2 - SvO2) and ICU survi-
val. In a secondary analysis, we tested the hypothesis
whether the relationship between ScvO2 and SvO2 is
independent of sepsis origin or not.
Materials and methods
Setting
We studied ICU populations in two teaching hospitals:
the Martini Hospital (MH) (Groningen, The Nether-
lands), where the ICU is a 14-bed ‘closed format’ mixed
medical/surgical ICU department, and the Medical Cen-
ter Leeuwarden (MCL) (Leeuwarden, The Netherlands),
where the ICU is a 16-bed ‘closed format’ mixed medi-
cal/surgical ICU, including cardiothoracic patients. The
study was approved by both local ethics committees.
Informed consent was obtained in all cases from the
patient or the patient’s legal representative.
Patients and data collection
This prospective observational study included patients (at
least 18 years old) with sepsis or septic shock according
to international criteria [11] between January and Sep-
tember 2009. Only patients in whom there was a clinical
indication for additional hemodynamic monitoring using
a pulmonary artery catheter (PAC) (Criticath SP 5507 H
TD; Becton Dickinson, Singapore) or a continuous car-
diac output (CCO) catheter (Arrow Deutschland GmbH,
Erding, Germany) were included. The catheter was
inserted in an internal jugular vein or subclavian vein in
accordance with standard procedure. Position was con-
firmed by the presence of pulmonary artery pressure tra-
cings and chest radiography. No complications other
than transient arrhythmias were observed during the
insertion of any catheter. Primary data, including hemo-
dynamic parameters, were collected at 6-hour intervals
(T0, T1, T2, T3, T4) during the first 24 hours after acute
ICU admission. Standard blood samples (2 mL) were
drawn simultaneously from distal (pulmonary artery) and
proximal/side (superior caval vein) ports from the PAC
or CCO catheter. To avoid falsely high readings because
of aspiration of pulmonary capillary blood, aspiration was
done gently to avoid high negative pressure when blood
samples were taken. We took blood from the proximal
port of the catheter as representative of central venous
blood [6,8,10]. We did not use any continuously mea-
sured values of the catheter itself in the cases in which a
CCO catheter was used. Only patients with a complete
series of five paired measurements were finally included.
Also, arterial blood samples, including serum lactate,
were obtained. All blood samples were analyzed by a
co-oximeter (Radiometer ABL800 flex; Radiometer,
Copenhagen, Denmark). The Acute Physiology and
Chronic Health Evaluation II (APACHE II) score after
24 hours of ICU admission was collected [12].
Statistical analysis
Analysis was conducted for the total population, and for
secondary analysis, the population was divided into two
groups: patients with a splanchnic source of sepsis and
patients with a non-splanchnic source of sepsis. We cal-
culated a sample size of 200 paired samples to detect an
absolute difference between ScvO2 and SvO2 in a two-
sided test with a 0.05 type I error and a 95% probability
in case of standard deviation of 10% [13,14]. Statistical
tests were two-tailed and performed by the statistical
package for the social sciences (SPSS 16.0.1 for Windows;
SPSS Inc., Chicago, IL, USA) or MedCalc software (ver-
sion 11.2.1; MedCalc Software, Mariakerke, Belgium).
The latter were used for comparing receiver operating
characteristic (ROC) curves. GraphPad software (Prism
5.0; GraphPad Software, Inc., La Jolla, CA, USA) was
used for graphics. Measurements were not independent
but were clustered within each patient. All data were
tested for normal distribution with the Kolmogorov-
Smirnov test before further statistical analysis. Differ-
ences between the two groups were assessed by using the
Student t test in case of normal distribution or the c2
test. For each time point T0 toT4, (ScvO2 - SvO2) was
calculated including the average difference per patient.
The agreement between absolute values of ScvO2 and
SvO2 and the agreement of the changes of these values
were assessed by the mean bias and 95% limits of agree-
ment ([mean bias ± 1.96] × standard deviation) as
described by Bland and Altman [15]. The c2 test was
used to establish significance between the number of sur-
vivors and non-survivors. Spearman correlations for
assessing possible factors affecting (ScvO2 - SvO2) were
determined: at each time point, (ScvO2 - SvO2) was com-
pared with hemodynamic and perfusion variables.
For secondary analysis, we also calculated the mean
(ScvO2 - SvO2) per group, and these values were com-
pared by using Student unpaired t test. Additionally, the
influence on outcome of O2ER was determined because
(ScvO2 - SvO2) did correlate with O2ER in the second-
ary analysis. SvO2 and arterial oxygen saturation (SaO2)
were used in the calculation of the systemic oxygen
extraction ratio (O2ER). ROC curves were used for the
assessment of sensitivity and specificity of O2ER in pre-
dicting in-hospital mortality. Data were displayed as
mean ± standard deviation. Statistical significance was
assumed at a P value of less than 0.05.
Results
We enrolled 56 patients, of whom 3 patients were
excluded because of lack of data (technical problems).
We evaluated data from 53 patients with sepsis. Alto-
gether, 265 paired blood samples were obtained. Base-
line characteristics and outcome of the total population
and both groups are shown in Table 1. Length of stay in
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the ICU (LOSICU) was 12 ± 10 days, and length of stay
in the hospital (LOSHOSP) was 25 ± 18 days.
The ScvO2 overestimated the SvO2 by a mean bias (or
absolute difference) of 1.7% ± 7.1% in the total popula-
tion. The 95% limits of agreement were wide (-12.1% to
15.5%; Figure 1a). Figure 2 illustrates this: mean ScvO2
and mean SvO2 values are shown at each time point.
Results at time point T = 0 and at different time points
were similar, including wide limits of agreement (data
and plots not shown). Bias between changes of ScvO2
and SvO2 was 0.6% ± 7.1% in the total population, with
95% limits of agreement of -13.4% to 14.6% (Figure 1b).
Results were similar at time point T = 0 and at different
time points, including wide limits of agreement (data
and plots not shown).
Differences between survivors and non-survivors
As ScvO2 of 70% has been used as a target for guided
therapy in septic patients [4], we evaluated the frequen-
cies of ScvO2 values below 70% in both survivors and
non-survivors. Of all ScvO2 measurements in survivors,
15% fell below 70%, whereas in non-survivors, 47% of all
ScvO2 measurements fell below 70% (P < 0.01). Assum-
ing a 5% difference between ScvO2 and SvO2 [1], we
also evaluated the frequencies of SvO2 values below 65%
in both survivors and non-survivors. Of all measure-
ments in survivors, 7% fell below 65%, whereas in non-
survivors, 27% of all SvO2 measurements fell below 65%
(P < 0.01). Figure 3 shows the number of paired mea-
surements resulting in either an (ScvO2 - SvO2) of at
least 0 or an (ScvO2 - SvO2) of less than 0. There was
no significant different distribution of (ScvO2 - SvO2)
between survivors and non-survivors (P = 0.13).
Influence on difference between ScvO2 and SvO2
(ScvO2 - SvO2)
The difference between ScvO2 and SvO2 was dependent
on the level of ScvO2 when values of less than 60%, 60%
to 70%, 70% to 80%, and greater than 80% were ana-
lyzed separately. The mean (ScvO2 - SvO2) values were
8.9%, 1.0%, 2.4%, and 4.2%. Owing to a low incidence
(4.9%) of low ScvO2 values (< 60%), we did not assess
statistics on these differences. Assessment of Spearman
correlation coefficients did not show any relation
between cardiac output, cardiac index, dopamine (μg/kg
per minute), norepinephrine (μg/kg per minute), mean
arterial blood pressure, arterial saturation, hemoglobin,
hematocrit, pH, or lactate levels and (ScvO2 - SvO2) (all
P > 0.05). O2ER correlated significantly with (ScvO2 -
SvO2) at all time points (all P < 0.01).
Differences between groups
Secondary analysis showed that 25 patients presented
with a splanchnic source of sepsis and 28 patients pre-
sented with a non-splanchnic source of sepsis. Thirty
patients (15 splanchnic and 15 non-splanchnic) were
enrolled in the MCL, and 23 (10 splanchnic and 13
non-splanchnic) patients were enrolled in the MH. The
sources of sepsis in the non-splanchnic group were
mainly pneumonia (n = 16; 57%) and infection of the
urogenital tract (n = 5; 18%). Other sources were
meningitis, arthritis, epiglottitis, endocarditis, and
infected soft tissue. At baseline, SvO2 (75.2% ± 9.9% ver-
sus 68.6% ± 10.5%; P = 0.03) was different between
groups. There was no significant difference between the
mean (ScvO2 - SvO2) of the two groups: splanchnic,
0.8% ± 3.9% versus non-splanchnic, 2.5% ± 6.2% (P =
0.30). Biases between ScvO2 and SvO2 were 0.7% ± 6.3%
(95% limits of agreement of -11.7% to 13.1%) in the
splanchnic group and 2.6% ± 7.5% (95% limits of agree-
ment of -12.2% to 17.4%) in the non-splanchnic group.
Biases between changes in ScvO2 and SvO2 were 0.9% ±
7.9% (95% limits of agreement of -14.5% to 16.3%) in
the splanchnic group and 0.3% ± 6.5% (95% limits of
agreement of -12.4% to 13.0%) in the non-splanchnic
group (plots not shown). The difference between ScvO2








Age, years 66 ± 12 66 ± 12 66 ± 13 0.46
Central venous pressure, mm Hg 12 ± 6 11 ± 5 14 ± 6 0.06
Mean arterial pressure, mm Hg 66 ± 10 65 ± 12 66 ± 9 0.65
ScvO2, percentage 72.0 ± 10.0 73.7 ± 10.5 70.6 ± 9.6 0.29
SvO2, percentage 71.8 ± 10.6 75.2 ± 9.9 68.6 ± 10.5 0.03
b
Lactate, mmol/L 3.5 ± 3.5 3.8 ± 3.8 3.5 ± 3.2 0.33
Arterial pH 7.30 ± 0.10 7.29 ± 0.10 7.29 ± 0.12 0.43
Hematocrit, percentage 30.1 ± 5.7 30.2 ± 6.1 32.1 ± 5.7 0.59
APACHE II score 26.6 ± 7.6 25.3 ± 7.3 28.7 ± 7.8 0.24
Hospital mortality, percentage 26.5 29.2 24.0 0.56
Data are presented as mean ± standard deviation unless otherwise indicated. aSplanchnic group versus non-splanchnic group. bStatistically significant difference.
APACHE II, Acute Physiology and Chronic Health Evaluation II; ScvO2, central venous oxygen saturation; SvO2, mixed venous oxygen saturation.
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and SvO2 was dependent on the level of ScvO2 when
values of less than 60%, 60% to 70%, 70% to 80%, and
greater than 80% were analyzed separately. The mean
(ScvO2 - SvO2) values were 12.3%, 2.1%, 1.0%, and
4.3% for the splanchnic group and 4.6%, 0.1%, 3.8%,
and 4.7% for the non-splanchnic group. There was no
significant different distribution of (ScvO2 - SvO2)
between survivors and non-survivors in either the
splanchnic group (P = 0.23) or the non-splanchnic
group (P = 0.13) (Figure 3).
Figure 1 Bland and Altman plot showing the agreement between (a) ScvO2 and SvO2 (bias 1.7, 95% limits of agreement from -12.1 to
15.5) and in (b) changes in ScvO2 and SvO2 (bias 0.6, 95% limits of agreement from -13.4 to 14.6). ScvO2, central venous saturation; SvO2,
mixed venous saturation.
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Oxygen extraction ratio
The O2ER in the splanchnic group was similar to the
O2ER in the non-splanchnic group (0.23 ± 0.07 versus
0.24 ± 0.09; P = 0.23). Figure 4 shows the ROC curves
of O2ER for the splanchnic and non-splanchnic groups.
Optimal values of O2ER were 0.22 (sensitivity = 0.46,
specificity = 0.87) for the non-splanchnic group and
0.31 (sensitivity = 0.85, specificity = 0.40) for the
splanchnic group. These curves represent the reliability
of the O2ER as a predictor of in-hospital mortality. The
area under the curve (AUC) in the splanchnic group
was not significantly larger than the AUC in the non-
splanchnic group (0.67 versus 0.55; P = 0.20).
Discussion
We could confirm our hypothesis that ScvO2 does not
reliably predict SvO2 in patients with severe sepsis: the
agreement of ScvO2 and SvO2 was clinically not ade-
quate. The difference between ScvO2 and SvO2 varied
according to the level of ScvO2 and was the greatest in
low (< 60%) and high (> 80%) ranges. In patients with
severe sepsis or septic shock, the difference between
ScvO2 and SvO2 appears not to be a fixed one and does
not seem to be predictive for in-hospital mortality.
Finally, the difference between ScvO2 and SvO2 is inde-
pendent of several hemodynamic variables, with the
exception of O2ER.
The bias was small, and ScvO2 was consistently larger
than SvO2. However, this consistent bias also implies a
greater relative error for SvO2 values at lower ScvO2
values. Additionally, the wide limits of agreement between
ScvO2 and SvO2 are unacceptably wide and independent
of time point. The widely assumed 5% difference between
ScvO2 and SvO2 [1,8,9] seems not to be consistent in
patients with severe sepsis or septic shock. A variety of
factors influence the difference between both variables in
patients with sepsis: mixing of the less saturated blood
from the coronary sinus in the right atrium, sepsis-related
vasodilatation, heterogeneity of flow within and between
organs, and decreased cerebral oxygen uptake during seda-
tion. On the basis of the present study, the net effect of
these factors seems unpredictable. Our results seem con-
cordant with earlier findings [6,8,16]. The first study
described a small heterogeneous group of patients with
septic shock. ScvO2 was consistently higher than SvO2,
and the limits of agreement were equally wide. Moreover,
the difference between ScvO2 and SvO2 varied according
to the level of ScvO2 and deviated in the extreme ranges
(60% < ScvO2 > 80%) [6]. The lower range (venous satura-
tions of less than 60%) is clinically of the greatest interest
because the patients admitted with such low venous
saturations are the ones who could possibly benefit from
ScvO2-guided therapy [4]. With the results of the present
study in mind, the clinician should be aware of the large
Figure 2 Mean mixed venous saturation (SvO2) and central venous saturation (ScvO2) values at different time points. ScvO2 is
consistently higher than SvO2 without statistical difference (paired t test; all P > 0.05).
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variability between ScvO2 and SvO2. Clinically important,
this large variability was already present on admission
(T = 0). At this time point, the first decisions on how to
resuscitate and on what goals should be achieved are
made. Such large uncertainty in estimating SvO2 by ScvO2
is unlikely to be suitable for protocol-guided resuscitation
in which decreases in SvO2 or ScvO2 may trigger thera-
peutic interventions. Normalization of ScvO2 after resusci-
tation will not automatically imply normalization of SvO2.
If the individual values of ScvO2 and SvO2 do not
agree, could this be different for the trends of ScvO2
and SvO2? In anesthetized subjects who underwent
Figure 3 Number of paired measurements resulting either in an (ScvO2 - SvO2) of at least 0 (dark bars) or in an (ScvO2 - SvO2) of less
than 0 (light bars). There was no significantly different distribution of (ScvO2 - SvO2) between survivors and non-survivors in (a) the total
population (P = 0.13), (b) the splanchnic group (P = 0.23), or (c) the non-splanchnic group (P = 0.13). The c2 test was used to establish
significance between the number of survivors and non-survivors. ScvO2, central venous saturation; SvO2, mixed venous saturation.
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elective neurosurgery, measurement of oxygen satura-
tions was performed in various hemodynamic condi-
tions. It was concluded that for clinical purposes the
trend of ScvO2 may be substituted for the trend of SvO2
[17]. In the present study, however, we found wide lim-
its of agreement between the change of ScvO2 and the
change of SvO2 in critically patients. As for the absolute
values of ScvO2 and SvO2, substitution of the change of
ScvO2 for the change of SvO2 in patients with sepsis is
therefore undesirable. This is in concordance with ear-
lier findings in patients with cardiogenic or septic shock:
changes in ScvO2 and SvO2 did not follow the line of
perfect agreement, and ScvO2 and SvO2 were not con-
sidered to be interchangeable [18].
Another issue is whether an ScvO2 of 70% as a treat-
ment goal in sepsis or septic shock after resuscitation
Figure 4 Receiver operating characteristic curves of oxygen extraction ratio for the splanchnic and non-splanchnic groups. The area
under the curve (AUC) in the splanchnic group was not significantly larger than AUC in the non-splanchnic group (0.67 versus 0.55; P = 0.20).
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may be considered useful. In a study by Reinhart and
colleagues [5], ScvO2 was measured continuously in cri-
tically ill patients for an average of 42 hours. More than
87% of the values in non-survivors and 95% of the
values in survivors were above 70%. This difference was
significant. Average time per patient below the cutoff
value was twice as long in non-survivors [5]. In the
present study, ScvO2 values in non-survivors fell more
frequently below the cutoff value of 70% compared with
survivors, and SvO2 values below 65% were more
frequently found in non-survivors compared with survi-
vors. Our data suggest that, after the first hours of
resuscitation, monitoring of venous oxygen saturations
could still be clinically relevant.
More recently, Gutierrez and colleagues [10] described
an association between a positive (ScvO2 - SvO2) and
ICU survival in critically ill patients. A significantly
greater number of survivors had an (ScvO2 - SvO2) of at
least 0 compared with non-survivors. The difference
between ScvO2 and SvO2 became increasingly positive
in survivors from initial to final measurement. The
authors suggested that this may be associated with clini-
cal recovery, perhaps reflecting a greater rate of O2 utili-
zation [10]. A similar trend was observed in post-
operative cardiac patients [19]. Although we noted that
(ScvO2 - SvO2) was more frequently positive in survi-
vors and that O2ER correlated with (ScvO2 - SvO2), we
found no significant difference in distribution of (ScvO2
- SvO2) between survivors and non-survivors. Our
results could not confirm a greater rate of O2 utilization
in survivors as suggested by Gutierrez and colleagues
[10]. However, it is possible that the number of mea-
surements in our study was not sufficient to detect a
difference in distribution of (ScvO2 - SvO2).
Secondary analysis showed that the inconsistent differ-
ence between ScvO2 and SvO2 is independent of sepsis
origin. There was no significant difference between the
mean (ScvO2 - SvO2) of the two groups, and the limits of
agreement were wide both for the absolute values and for
the changes in ScvO2 and SvO2. SvO2 values were higher
in the splanchnic group compared with the non-splanch-
nic group for a certain ScvO2 value. This phenomenon
could be explained by sepsis-related vasodilatation in the
digestive tract. Despite heterogeneity of flow within and
between various organs in patients with splanchnic sepsis
[20], this leads to diminished oxygen consumption,
which results in a higher SvO2. Apparently, a normal
SvO2 does not rule out the presence of limited oxygen
consumption in the splanchnic region [7]. Moreover, we
found no difference in O2ER between the splanchnic and
non-splanchnic groups. This suggests less oxygen utiliza-
tion in the digestive tract than could be expected on the
basis of the assumption that in all septic patients the dif-
ference between ScvO2 and SvO2 equals 5%.
This study has limitations. First, all patients were
sedated and mechanically ventilated and none of them
was in hemorrhagic shock. Our findings may not be
generalized to patients who are less critically ill or those
with hemorrhagic shock. Also, owing to intubation,
ScvO2 values could have been relatively high in relation
to disease severity [21]. Second, we investigated ICU
patients, who may have been in a later stage of sepsis;
timing of measurements was probably not all in the
same stage of critical illness. Third, in this study, ScvO2
and SvO2 values did not change between different time
points as a result of a protocolized intervention: conclu-
sions on independence of time points are of limited
value. However, measurements were conducted within
individual patients: each subject served as his or her
own control. Finally, we used the proximal port of the
catheters as a surrogate of ScvO2. A more distal location
in the right atrium allows mixing of superior and infer-
ior caval vein blood, and some ScvO2 measurements
might have been influenced by this. Nevertheless, our
results are consistent with those of previous studies in
which a similar technique was used [6,8,10].
Conclusions
We conclude that ScvO2 does not reliably predict SvO2
in patients with sepsis, independently of sepsis origin.
Assuming a consistent 5% difference between ScvO2
and SvO2 can lead to erroneous clinical decisions. The
change of ScvO2 compared with the change of SvO2 is
not more reliable than the exact numerical values in
this context. Finally, a positive (ScvO2 - SvO2) value is
not associated with improved outcome in patients with
sepsis. The abovementioned conclusions apply to sepsis
of either splanchnic or non-splanchnic origin.
Key messages
• Central venous saturation (ScvO2) does not reliably
predict mixed venous saturation (SvO2) in patients
with sepsis, independently of sepsis origin.
• The change of ScvO2 compared with the change of
SvO2 is not more reliable than the exact numerical
values in patients with sepsis.
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